ClinicalTrials.Veeva

Menu

Immediate Versus Delayed IUD Insertion After Second Trimester Medical Abortion

U

University of Cape Town (UCT)

Status

Completed

Conditions

Contraception

Treatments

Device: Copper Intrauterine device

Study type

Interventional

Funder types

Other

Identifiers

NCT03505047
007/2018

Details and patient eligibility

About

The main objective of the study is to compare use, in a randomised controlled trial, of the the copper IUD if inserted immediately after completion of a second trimester medical abortion, to standard care with insertion 3-4 or more weeks after abortion at community health centres.

Enrollment

110 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Able to speak English, Afrikaans or Xhosa;
  • Requesting and eligible for abortion according to standard practice at the hospital;
  • Gestational age 13-20 weeks verified by ultrasound;
  • Interested and eligible for the copper IUD as a post-abortion contraceptive method;
  • Willingness to participate in the trial including follow-up;
  • Able to provide a working phone & telephone number to allow for contact;
  • Willing and able to provide informed consent
  • Staying within one hour travel time of GSH

Exclusion criteria

  • Active pelvic inflammatory disease, pelvic tuberculosis; severe thrombocytopenia;
  • Positive N. Gonorrhea or C. Trachomatis that has not been adequately treated
  • Copper allergy
  • Hb <10g/dL
  • Uterine anomaly preventing placement of the IUD; cervical cancer or carcinoma in-situ, untreated high grade squamous intraepithelial lesions
  • Hemorrhage; or ruptured uterus
  • History of ectopic pregnancy
  • Wilsons' disease

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

110 participants in 2 patient groups

Immediate group:
Experimental group
Description:
The Copper Intrauterine device will be inserted within 24 hours of the expulsion of the fetus and placenta or after surgical evacuation for placental remains, and prior to discharge from the facility.
Treatment:
Device: Copper Intrauterine device
Delayed Group
No Intervention group
Description:
The Copper Intrauterine device will be inserted at a local community health centre 14-28 days after discharge.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems